Mereo Interest Income from 2010 to 2026
| MREO Stock | USD 0.41 0.01 2.38% |
Interest Income | First Reported 2010-12-31 | Previous Quarter 3.5 M | Current Value 3.7 M | Quarterly Volatility 1.3 M |
Check Mereo BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mereo BioPharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.7 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 28.79, Dividend Yield of 0.0 or PTB Ratio of 8.02. Mereo financial statements analysis is a perfect complement when working with Mereo BioPharma Valuation or Volatility modules.
Mereo | Interest Income | Build AI portfolio with Mereo Stock |
Evaluating Mereo BioPharma's Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Mereo BioPharma Group's fundamental strength.
Latest Mereo BioPharma's Interest Income Growth Pattern
Below is the plot of the Interest Income of Mereo BioPharma Group over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Mereo BioPharma's Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mereo BioPharma's overall financial position and show how it may be relating to other accounts over time.
| Interest Income | 10 Years Trend |
|
Interest Income |
| Timeline |
Mereo Interest Income Regression Statistics
| Arithmetic Mean | 875,828 | |
| Geometric Mean | 134,061 | |
| Coefficient Of Variation | 150.78 | |
| Mean Deviation | 1,039,747 | |
| Median | 183,000 | |
| Standard Deviation | 1,320,572 | |
| Sample Variance | 1.7T | |
| Range | 3.7M | |
| R-Value | 0.78 | |
| Mean Square Error | 726B | |
| R-Squared | 0.61 | |
| Significance | 0.0002 | |
| Slope | 204,195 | |
| Total Sum of Squares | 27.9T |
Mereo Interest Income History
Other Fundumenentals of Mereo BioPharma Group
Mereo BioPharma Interest Income component correlations
Click cells to compare fundamentals
About Mereo BioPharma Financial Statements
Mereo BioPharma investors utilize fundamental indicators, such as Interest Income, to predict how Mereo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Interest Income | 3.5 M | 3.7 M | |
| Net Interest Income | 1.9 M | 2 M |
Pair Trading with Mereo BioPharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mereo BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Mereo Stock
Moving against Mereo Stock
| 0.72 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.65 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.55 | ENGN | enGene Holdings Common | PairCorr |
| 0.42 | DSGN | Design Therapeutics | PairCorr |
| 0.4 | KYTX | Kyverna Therapeutics | PairCorr |
The ability to find closely correlated positions to Mereo BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mereo BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mereo BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mereo BioPharma Group to buy it.
The correlation of Mereo BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mereo BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mereo BioPharma Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mereo BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Mereo BioPharma Correlation against competitors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Will Biotechnology sector continue expanding? Could Mereo diversify its offerings? Factors like these will boost the valuation of Mereo BioPharma. Expected growth trajectory for Mereo significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mereo BioPharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Mereo BioPharma Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mereo BioPharma's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mereo BioPharma's market price to deviate significantly from intrinsic value.
Understanding that Mereo BioPharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mereo BioPharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mereo BioPharma's market price signifies the transaction level at which participants voluntarily complete trades.